DSIJ Mindshare

FIIs Bought 23,613 Shares: This Bioscience Company Advances Rs 176 Crore Facility and Plans Early Launch of Avian Influenza Vaccine in Q2FY26

On YTD basis stock is down by 24 per cent, while in last 12 months it is up by 3 per cent.

DSIJ Intelligence-2 0 151 Article rating: 4.6

On YTD basis stock is down by 24 per cent, while in last 12 months it is up by 3 per cent.

This small-cap stock rallied over 6 per cent on the back of stellar Q3FY23 results!

 The Fill-finish (Drug Product) project will be completed in Q1 FY24 as against the earlier forecasted date of Q4 FY23

DSIJ Intelligence-3 0 636 Article rating: 4.4

The stock rallied over 6 per cent on Tuesday and interestingly, the up-move was seen on back of highest single day volume in the since September 2022. Also, the stock moved above its 20-DMA and the daily 14-period RSI inching closer to 60-mark.

Watch out for this lumpy skin disease beneficiary stock that planned capacity expansion, zooms 15 per cent!

The stock returns on Monday have shot through the roof as it jumped nearly 15 per cent on a day when markets are in turmoil. Hence, keep a close watch on this stock

DSIJ Intelligence-3 0 807 Article rating: 4.3

For manufacturing additional quantities of the vaccine and ensuring the continuance of manufacturing & supplying of all other vaccines against poultry, sheep, goat, and cattle, the company is undergoing capacity expansion, which is expected to be completed by January 2023. 

RSS
12
DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR